CLN Clariant AG

12.54USD10.57 CHF · SWX-1.67%Mkt Cap: 4.12B USDP/E: —

Clariant AG develops, manufactures, distributes, and sells specialty chemicals in Switzerland, Europe, the Middle East, Africa, the United States, and the Asia Pacific. It operates through Care Chemicals, Catalysts, and …

Institutional holders11 on file

Key Statistics

Company
Market Cap4.12B USD
Enterprise Value6.09B USD
Revenue (TTM)4.50B USD
Gross Profit1.39B USD
Net Income (TTM)-89.00M USD
Revenue/Share13.68 USD
Last Price12.54 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees10.1K
CountryCH
SectorBasic Materials
IndustrySpecialty Chemicals
ISINCH0012142631
Valuation
P/E (Trailing)—
P/E (Forward)12.40
PEG0.73
EV/EBITDA9.09
EV/Revenue1.35
P/S0.92
P/B1.72
EPS (TTM)-0.12 USD
EPS (Forward)1.01 USD
52W Range
7.77287% of range13.24
52W High13.24 USD
52W Low7.772 USD
Profitability
Gross Margin29.94%
Oper. Margin9.58%
EBITDA Margin14.89%
Profit Margin-1.92%
ROE-3.71%
ROA-1.28%
ROIC4.41%
ROCE6.90%
Growth
Revenue Growth-6.10%
Earnings Growth162.50%
Cash Flow & Leverage
Operating CF497.20M USD
CapEx (TTM)173.25M USD
FCF Margin5.65%
FCF Yield6.17%
Net Debt1.77B USD
Net Debt/EBITDA2.64
Net Debt/FCF6.96
Balance Sheet
Debt/Equity1.00
Current Ratio1.77
Quick Ratio0.95
Book Value/Sh7.27 USD
Cash/Share2.29 USD
Dividends
Fwd Div Rate0.50 USD
Trail. Div Rate0.50 USD
Div. Yield3.91%
5Y Avg Yield3.68%
Payout Ratio123.53%
Ex-Div DateJun 2, 2026
Pay DateJun 3, 2024
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)13.96 USD
Upside (mean)+11.3%
Target Range9.968 USD – 16.61 USD
9.968+11.3% to mean16.61
# Analysts16
Ownership
Shares Out.328.88M
Float195.07M
Insiders5.36%
Institutions55.43%
Technical
SMA 5012.51 (+0.3%)
SMA 20010.46 (+19.9%)
Beta0.46
S&P 52W Chg12.00%
Avg Vol (30d)714.57K
Avg Vol (10d)756.08K
Technical Indicators
RSI (14)49.7
MACD0.1315
MACD Signal0.1537
MACD Hist.-0.0223
BB Upper13.30 USD
BB Middle12.58 USD
BB Lower11.86 USD
BB Width11.42%
ATR (14)0.3533 USD
Vol Ratio (20d)0.79x

About Clariant (SWX: CLN)

›

Clariant (SWX: CLN) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 10,107 employees.

The shares were at 10.57 CHF on 19 November 2026, up 50.5% over 52 weeks. Its 52-week range is 6.550 CHF to 11.16 CHF: the price is 5.3% below the high and 61.4% above the low.

Its market capitalisation is 3.48B CHF. It pays a dividend yielding 3.91% (it pays out 124% of its earnings), against a median of 1.76% among the dividend payers in that peer group.

Clariant reports return on equity of -3.7%, an operating margin of 9.6% and revenue down 6.1% year over year.

Its debt exceeds its cash by 1.49B CHF, a debt-to-equity ratio of 1.00. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 16 analysts cover the stock, with an average rating of Buy; their mean price target of 11.76 CHF is 11.3% above the current price. The next earnings report is expected on 23 February 2027.